Parathyroid tumor development involves deregulation of homeobox genes

Endocrine-Related Cancer

Volumn 15, Issue 1, 2008, Pages 267-275

  Shen, H C Jennifer ^a   Rosen, Jennifer E ^a   Yang, Lauren M ^a   Savage, Sharon A ^a   Burns, A Lee ^b   Mateo, Carmen M ^b   Agarwal, Sunita K ^b   Chandrasekharappa, Settara C ^c   Spiegel, Allen M ^b,d   Collins, Francis S ^c   Marx, Stephen J ^b   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; METHIONINE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE SEQUENCE; HOMEOBOX; HUMAN; HUMAN TISSUE; HYPOTHESIS; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROID NEOPLASMS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 41349092295     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0191     Document Type: Article

References (31)

1. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM et al. 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 143-152.
2. Bertolino P, Tong WM, Galendo D, Wang ZQ & Zhang CX 2003a Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Molecular Endocrinology 17 1880-1892.
3. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX & Wang ZQ 2003b Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research 63 4836-4841.
4. Brend T, Gilthorpe J, Summerbell D & Rigby PW 2003 Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression. Development 130 2717-2728.
5. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
6. Chen H & Sukumar S 2003 HOX genes: emerging stars in cancer. Cancer Biology and Therapy 2 524-525.
7. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, Silva A, Brown EJ, Hess JL, Pear WS & Hua X 2006 The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. PNAS 103 1018-1023.
8. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ et al. 2001 A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. PNAS 98 1118-1123.
9. Debelenko LV, Brambilla E, Agarwal SK, S walwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE et al. 1997 Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Human Molecular Genetics 6 2285-2290.
10. Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL & Lappin TR 2005 The pathophysiology of HOX genes and their role in cancer. Journal of Pathology 205 154-171.
11. Guru SC, Manickam P, Crabtree JS, Olufemi SE, Agarwal SK & Debelenko LV 1998 Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. Journal of Internal Medicine 243 433-439.
12. Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, van Puijenbroek M, Furge K, Kievit J, Tan MH, Fleuren GJ et al. 2004 Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Research 64 7405-7411.
13. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL et al. 1997 Somatic mutation of the MEN1 gene in parathyroid tumours. Nature Genetics 16 375-378.
14. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ et al. 2001 The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 4917-4925.
15. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA et al. 2004 Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Molecular Cell 13 587-597.
16. Kaji H, Canaff L, Lebrun JJ, Goltzman D & Hendy GN 2001 Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. PNAS 98 3837-3842.
17. Kondo T & Duboule D 1999 Breaking colinearity in the mouse HoxD complex. Cell 97 407-417.
18. Krumlauf R 1994 Hox genes in vertebrate development. Cell 78 191-201.
19. Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O'Connor S, Ward JM, Emmert-Buck MR, Remaley A et al. 2003 Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Research 63 8022-8028.
20. Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK & Kay GF 2007 Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. International Journal of Cancer 120 259-267.
21. Manley NR & Capecchi MR 1998 Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Developmental Biology 195 1-15.
22. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS & Nordeen SK 2003 Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Research 63 5879-5888.
23. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J & Sukumar S 2000 Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405 974-978.
24. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS et al. 2006 Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genetics 2 e51.
25. Shim C, Zhang W, Rhee CH & Lee JH 1998 Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clinical Cancer Research 4 3045-3050.
26. Spitz F, Gonzalez F & Duboule D 2003 A global control region defines a chromosomal regulatory landscape containing the HoxD cluster. Cell 113 405-447.
27. Takahashi Y, Hamada J, Murakawa K, Takada M, Tada M, Nogami I, Hayashi N, Nakamori S, Monden M, Miyamoto M et al. 2004 Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Experimental Cell Research 293 144-153.
28. Waltregny D, Alami Y, Clausse N, de Levai J & Castronovo V 2002 Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50 162-169.
29. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr & Sawicki MP 1998 Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Research 58 4417-4420.
30. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W & Cleary ML 2004 Leukemia protooncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Molecular and Cellular Biology 24 5639-5649.
31. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M & Cleary ML 2005 The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 207-218.